Quiz: Multiple Myeloma Incidence in 2017
How many people this year are expected to be diagnosed with multiple myeloma in the United States? And how does the rate of incidence differ between black patients and white patients, or between men and women? Test your knowledge on multiple myeloma in our latest quiz.
How many people this year are expected to be diagnosed with multiple myeloma in the United States? And how does the rate of incidence differ between black patients and white patients, or between men and women? Test your knowledge on multiple myeloma in our latest quiz.
Question 1
Answer and Question 2 on Next Page »
Answer
B.False
Multiple myeloma is more common in men than in women.
Question 2
Answer and Question 3 on Next Page »
Answer
D. 30,280
This year, according to the American Cancer Society, it is estimated that 17,490 men and 12,790 women will be diagnosed with multiple myeloma.
Question 3
Answer and Question 4 on Next Page »
Answer
C. 12,590
This year it is estimated that 6,660 men and 5,930 women with multiple myeloma will die from their disease, according to the American Cancer Society.
Question 4
Answer
A. True
According to one study, 14.8 black men and 10.5 black women per every 100,000 are diagnosed with multiple myeloma in the United States compared with 7.2 white men and 4.3 white women per every 100,000.
FDA Approves Cilta-Cel for Relapsed/Refractory Myeloma After 1 Therapy
April 6th 2024The FDA has approved ciltacabtagene autoleucel for the treatment of adult patients with relapsed/refractory multiple myeloma who have received at least 1 prior line of treatment, including a proteasome inhibitor and an immunomodulatory agent, and are refractory to lenalidomide.
Relapsed/Refractory Multiple Myeloma Trial Updates From ASCO 2023
August 7th 2023Experts from Mayo Clinic and The University of Texas MD Anderson Cancer Center discuss results from multiple myeloma trials presented at the 2023 American Society of Clinical Oncology Annual Meeting and how they may apply to clinical practice.
